Anthony @ Equity Investigations, Dear Anthony, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony,

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Kelly who wrote (43135)	8/24/1999 4:32:00 PM
From: Fast Eddie	Read Replies (2) of 122087

<BCRX> Here's the news that moved the stock, it's not the trial results. I covered early today for a point loss. This analist is widely followed. It's very significant news," said Meirav Chovav, an analyst at Salomon Smith Barney. Chovav raised her 12-month price target for the stock to $35 a share from $25 and forecast narrower losses for the company in the 1999 and 2000 fiscal years. Chovav said she expects the BioCryst to turn profitable sooner than previously estimated. 1/2Fast Eddie

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next